JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4576
iShares Global Industrials ETF
EXI
$1.46B
| $504K | ﹤0.01% |
3,954
+2,933
| +287% | +$342K |
2023 Q1
3 quarters
|
|
4577
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.85B
| $504K | ﹤0.01% |
9,470
-2,936
| -24% | -$148K |
2020 Q1
15 quarters
|
|
4578
Artivion
AORT
$1.09B
| $503K | ﹤0.01% |
28,121
-1,969
| -7% | -$30.6K |
2016 Q2
30 quarters
|
|
|
FINV
4579
FinVolution Group
FINV
$685M
| $501K | ﹤0.01% |
102,264
-17,822
| -15% | -$84.6K |
2017 Q4
24 quarters
|
|
|
NGMS
4580
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $501K | ﹤0.01% |
17,489
-6,616
| -27% | -$179K |
2021 Q1
11 quarters
|
|
4581
Global X MLP ETF
MLPA
$2.28B
| $498K | ﹤0.01% |
11,236
-194
| -2% | -$8.65K |
2021 Q1
11 quarters
|
|
4582
Invesco Agriculture Commodity Strategy No K-1 ETF
PDBA
$493M
| $497K | ﹤0.01% |
+16,658
| New | +$532K |
2023 Q4
0 quarters
|
|
|
SFIX
4583
Stitch Fix
SFIX
$349M
| $497K | ﹤0.01% |
139,182
+28,489
| +26% | +$101K |
2018 Q2
22 quarters
|
|
4584
Direxion Daily S&P 500 Bear 1X ETF
SPDN
$224M
| $497K | ﹤0.01% |
37,385
+30,340
| +431% | +$435K |
2023 Q2
2 quarters
|
|
|
LGTY
4585
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $496K | ﹤0.01% |
43,913
-22,430
| -34% | -$241K |
2017 Q4
24 quarters
|
|
|
TBPH
4586
DELISTED
Theravance Biopharma
TBPH
| $496K | ﹤0.01% |
44,089
-3,621
| -8% | -$36.4K |
2015 Q4
32 quarters
|
|
4587
Nurix Therapeutics
NRIX
$2.39B
| $495K | ﹤0.01% |
47,990
-4,901
| -9% | -$33.6K |
2020 Q3
13 quarters
|
|
4588
Goldman Sachs Access Inflation Protected USD Bond ETF
GTIP
$287M
| $495K | ﹤0.01% |
10,113
+1,629
| +19% | +$77.6K |
2022 Q4
4 quarters
|
|
4589
Orthofix Medical
OFIX
$370M
| $494K | ﹤0.01% |
36,636
-400
| -1% | -$4.7K |
2015 Q2
34 quarters
|
|
4590
Preformed Line Products
PLPC
$2.05B
| $494K | ﹤0.01% |
3,687
+1,970
| +115% | +$266K |
2017 Q4
24 quarters
|
|
|
EMO
4591
ClearBridge Energy Midstream Opportunity Fund
EMO
$1,000M
| $493K | ﹤0.01% |
14,129
+5,455
| +63% | +$178K |
2021 Q4
8 quarters
|
|
|
FSR
4592
DELISTED
Fisker Inc.
FSR
| $493K | ﹤0.01% |
281,884
+40,778
| +17% | +$144K |
2020 Q4
12 quarters
|
|
4593
Tango Therapeutics
TNGX
$3.92B
| $493K | ﹤0.01% |
49,803
+2,551
| +5% | +$22.1K |
2021 Q3
9 quarters
|
|
4594
CALL
West Pharmaceutical
WST
$25.7B
| $493K | ﹤0.01% |
1,400
-45,500
| -97% | -$16.1M |
2023 Q3
1 quarter
|
|
4595
Banco Bradesco
BBDO
$33.5B
| $491K | ﹤0.01% |
154,532
| – | – |
2022 Q3
5 quarters
|
|
4596
Bank of Marin Bancorp
BMRC
$449M
| $491K | ﹤0.01% |
22,283
+10,934
| +96% | +$210K |
2014 Q1
39 quarters
|
|
4597
Tejon Ranch
TRC
$443M
| $491K | ﹤0.01% |
28,523
+11,572
| +68% | +$188K |
2015 Q4
32 quarters
|
|
|
SLGC
4598
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $490K | ﹤0.01% |
193,865
+2,345
| +1% | +$5.46K |
2022 Q2
6 quarters
|
|
4599
ProShares S&P Technology Dividend Aristocrats ETF
TDV
$276M
| $488K | ﹤0.01% |
+7,014
| New | +$451K |
2023 Q4
0 quarters
|
|
4600
CALL
Wingstop
WING
$2.91B
| $488K | ﹤0.01% |
+1,900
| New | +$410K |
2023 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.